Karen Reckamp, M.D., M.S., has been named assistant professor of medicine in the Lung Cancer and Thoracic Oncology Program at City of Hope. She will design and conduct clinical trials that turn scientific theories into new treatments to attack lung tumors.

Reckamp was previously an assistant professor of medicine at the David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at UCLA. She was awarded a prestigious three-year Career Development Award from the Department of Veterans Affairs to investigate new approaches to treating lung cancer as well as a career grant from the National Cancer Institute.

Reckamp also was selected for an American Society of Clinical Oncology Foundation Young Investigator Award for her research on cyclooxygenase-2 (COX-2) and epidermal growth factor receptor activity in non-small cell lung cancer. She has been principal investigator or co-principal investigator on several National Cancer Institute-funded research projects, including studies of novel therapies for advanced lung cancer.

“At a very early stage in her career, Dr. Reckamp is already an accomplished and respected translational researcher,” said Kemp Kernstine, M.D., Ph.D., director of the Department of Thoracic Surgery and the Lung Cancer Program. “She embraces the concept City of Hope upholds of caring for the whole patient with a multidisciplinary team approach, using clinical research to help improve outcomes for patients with cancer.”

Posted on February 3, 2007 09:14 AM